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ABSTRACT 
Little is known about the impact of eating disorders (ED) on pregnancy, infant growth 
and cognitive development. Preliminary reports indicate increased complications 
during pregnancy and lower birth weight in children of mothers with ED. There is need 
of prospective long-term follow-up of growth and cognitive development of the 
children of these mothers.     
Aims: To study the impact of ED on pregnancy and neonatal outcomes, maternal 
adjustment, and infant growth and cognitive development compared with controls.   
Method: Forty-nine nulliparous, nonsmoking women with a history of ED, 24 with 
anorexia nervosa (AN), 20 with bulimia nervosa (BN), 5 with non-specific ED 
(EDNOS), and 68 healthy controls were followed during pregnancy and up to three 
months postpartum. The women were recruited in early pregnancy from 13 antenatal 
clinics in northwestern Stockholm. Three months after delivery, the women completed 
the maternal adjustment and maternal attitude questionnaire (MAMA) and were asked 
about mental health problems postpartum. Furthermore, the children's growth (weight, 
height and head circumference) and neurocognitive development (questionnaire: Five 
to Fifteen) were followed up to five years of age. Blood samples during early 
pregnancy were analyzed for nutrition-related markers and stress factors (ferritin, 
cortisol, thyroid-stimulating hormone (TSH), free thyroxine (T4), insulin, insulin-like 
growth factor-I and binding protein 1). Serum levels of these biomarkers were related 
to head circumference and neurocognitive development of the offspring.      
Result: Eleven of the patients (22%) had verified relapse of ED during pregnancy. 
Pregnant women with past or active ED were at greater risk of delivering infants being 
small for gestational age, having lower birth weight and smaller head circumference 
than controls (Paper I). Three months after delivery, 92% of mothers with ED before 
pregnancy reported problems regarding their maternal adjustment compared to 13% in 
the control group, whereas there were no differences between the subgroups of ED. 
Fifty percent of mothers with previous ED reported that they had been in contact with 
health services after delivery because of depression or other mental problems (Paper 
II). Children of mothers with previous ED demonstrated an early catch-up in body mass 
index, while the average head circumference continued to be delayed up to at least 18 
months of age. The reduced head growth was related to delayed neurocognitive 
development in the ED group (Paper III). Serum levels of ferritin were significantly 
lower in the AN group, but not in the BN group, and correlated to impaired memory in 
the children at five years of age (Paper IV). Furthermore, maternal serum levels of free 
T4 were positively associated with head circumference of the children in both the AN 
group and the BN group, but not in the controls. 
Conclusion: Pregnant women with a history of AN or BN should be considered a risk 
group for prenatal and delivery complications. More research is needed, especially 
directed to the long-term growth and neurocognitive development of these children. 
Health care needs to improve its methods to identify a possible history of AN and BN 
in pregnant women and optimize care in order to prevent adverse health effects for 
mother and baby.  
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FOREWORD  
 
About 13 years ago, I took on the task of examining pregnant women with eating 
disorders (ED) compared to healthy controls. My long experience from working as a 
midwife had given me some insight to women with ED and the challenges they face in 
their pregnancy. I started to plan a research project focusing on ED during pregnancy at 
Karolinska Institutet. Even though I was not sure about the scope of the project at the 
time, I was convinced that there was a need to shed light on this complex subject. From 
my experiences at the outpatient clinic for youths, I realized that this field was 
characterized by preconceptions, probably due to the limited amount of research that 
had been done within the field. Most studies at the time on pregnant women with ED 
were small and inconclusive, e.g. parity and maternal smoking were not reported and 
there was a lack of control groups. To our knowledge, no research addressing the head 
circumference development had been conducted and, with one exception, children had 
not been followed up for longer than one year in earlier studies. I decided to dig deeper 
into the subject by taking a closer look at pregnancy, fetal development and growth of 
children to women with ongoing, or a history of ED. I contacted the Knowledge Centre 
for Eating Disorder in Stockholm, sought funding and got guidance on how to start the 
project. This has been a very long journey for me, but really an extremely exciting one! 
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1 INTRODUCTION 
 
1.1 EATING DISORDERS 
 
ED are divided into the main diagnoses of anorexia nervosa (AN), bulimia nervosa 
(BN) and eating disorder not otherwise specified (EDNOS) according to the Diagnostic 
and Statistical Manual of Mental Disorders, DSM-IV (APA 2000). Together, these 
disorders constitute one of the leading causes of disease burden in terms of years of life 
lost through disability or death for young women (Sattar et al., 1999). The peak age at 
onset occurs at a developmentally sensitive time in adolescence.  Lifetime prevalence 
rates for full and partial AN in women range from 0.9% to 4.3% and from 1.5% to 7% 
for full and partial BN (Favaro et al., 2003; Currin et al., 2005; Anderluh et al., 2009). 
Studies of time trends in ED show that the incidence and prevalence of AN and BN are 
stabilizing in Western countries (Favaro et al., 2003), whereas the prevalence of 
EDNOS continues to increase (Mond et al., 2008; Mond et al., 2009). ED are usually 
explained by multifactorial models including psychological, social, and biological risk 
factors. However, little research has attempted to bring together information about 
various types of risk factors and explore interactions among parental health and social 
characteristics, early-life environment, and individual aspirations in influencing the risk 
and long-term outcome of ED (Ahren-Moonga et al., 2009). 
 
1.2 ANOREXIA NERVOSA 
 
1.2.1 Clinical Characteristics 
AN is a serious psychiatric illness characterized by pronounced underweight; often 
well below 85 % of ideal body weight. Young individuals who are still growing fail 
to make expected increases in weight (and often height) and bone density. Despite 
severe underweight, individuals with AN remain dissatisfied with the perceived size 
of their bodies, and continue with unhealthy behaviors to perpetuate weight loss (e.g., 
dieting, purging, excessive exercise). In psychological terms, the weight and shape of 
the body may reflect the individual‟s self-esteem. Although amenorrhea is a 
diagnostic criterion, it is of questionable relevance for the disease (Watson & 
Andersen, 2003). Typical personality features of individuals with AN include 
perfectionism, compulsivity, anxiety, harm avoidance, and low self-esteem 
(Wonderlich et al., 2005).  
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The most common comorbid psychiatric conditions include major depression and 
anxiety disorders (Halmi et al., 1991; Kendler & Walters, 1995). Anxiety disorders 
often predate the onset of AN (Gendall et al., 1997; Frank et al., 2004) and depression 
often persists post-recovery (Sullivan et al., 1998). 
 
1.2.2 Diagnostic criteria 
Diagnostic criteria for AN according to DSM-IV (APA 2000) are shown below.  
 
Anorexia nervosa 
 Refusal to maintain body weight at or above a minimally normal weight for age and   
height (e.g. body weight less than 85% of that expected or body mass index < 17.5) 
 Intense fear of gaining weight or becoming fat, even though underweight 
 Disturbance in the way in which one´s body weight or shape is experienced  
 Amenorrhea, i.e. the absence of at least three consecutive menstrual cycles 
 
Subtypes 
Restricting type: The person has not regularly engaged in binge-eating or purging 
behaviour 
Binge eating/purging type: The person has regularly engaged in binge-eating or purging 
behaviour           (APA 2000) 
 
 
1.2.3 Epidemiology 
The lifetime prevalence of AN has been assessed in three large population-based 
cohort studies of twins reporting similar results. In a Swedish study, the overall 
prevalence of AN was 1.2% for females and 0.3% for male participants in the largest 
twin study from the 1935–1958 birth cohorts (Bulik et al., 2006). In an Australian 
study of female twins aged 28–39 years, the lifetime prevalence of AN was 1.9 % 
(Wade et al., 2006). In a Finnish study, the lifetime prevalence of AN was 2.2 % in a 
large sample of women from the 1975–1979 birth cohorts of Finnish twins (Keski-
Rahkonen et al., 2007). From the same birth cohorts, the lifetime prevalence of AN in 
men was 0.24 % (Raevuori et al., 2009). The overall incidence rate of AN has been 
stable over the past decades, but there has been an increase in the high risk-group of 
15-19 year old girls (Smink et al., 2012). 
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1.2.4 Etiology 
The etiology of AN remains incompletely understood. Although numerous 
psychological, social, psychosocial stress, biological and genetic factors have been 
implicated as potentially causal, few specific risk factors have been consistently 
replicated in studies of the etiology of the disorder. Common risk factors across ED 
include female sex, childhood eating and gastrointestinal problems, elevated shape 
and weight concerns, negative self-confidence, sexual abuse, and general psychiatric 
comorbidity (Brambilla, 2001; Jacobi et al., 2004; Bentley et al., 2005). In addition, 
prematurity and small for gestational age (SGA) have been identified as risk factors 
for AN in adulthood (Cnattingius et al., 1999).  
Several pharmacologic, genetic, and neuroimaging studies have identified 
fundamental disturbances in serotonergic function in individuals with AN even after 
recovery (Kaye et al., 2005). Although serotonin has received considerable research 
attention, other neurotransmitter systems, most notably dopamine, are also implicated 
in the disorder (Barbarich et al., 2003; Aaltonen et al., 2008). The ultimate 
understanding of AN etiology will likely include main effects of both biological and 
environmental factors, as well as their interactions and correlations. 
 
1.2.5 Medical complications 
Medical complications of AN are common and can affect multiple organ systems.  
Severe AN is associated with serious and potentially fatal cardiovascular 
complications including bradycardia, arrhythmias and hypovolemia, as well as 
electrolyte disturbances leading to sodium depletion, hypophosphatemia, and 
hypomagnesemia. 
AN is also associated with extensive endocrine abnormalities, which may affect 
puberty development in the young individuals and result in amenorrhea. Furthermore, 
low levels of estrogen together with nutritional deficiency will result in bone loss, 
particularly of trabecular bone, such as in the spine. Up to 50% of patients with AN 
have been found to have osteoporosis in the lumbar spine (Legroux-Gérot et al., 
2005). Other common medical complications are gastrointestinal disturbances 
including gastric dilatation, dental problems and dermatological changes. Medical 
consequences of AN can persist even after major recovery and may include continued 
low body mass index (BMI), osteoporosis (Rigotti et al., 1991) reproductive problems 
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(Bulik et al., 1999), and depression (Barraclough & Harris, 1998; Sullivan et al., 
1998). 
 
1.2.6 Treatment and prognosis 
The treatment of AN aims at restoring weight, normalizing eating behavior, treating 
psychological disturbances such as distortion of body image, low self-esteem, 
interpersonal conflicts, and achieving long-term remission and rehabilitation, and 
eventually full recovery (NICE 2004; APA 2006). In the acute phase of malnutrition 
and severe weight loss, hospitalization is needed for re-feeding and medical 
stabilization. In the outpatient treatment of AN, there is evidence for family-based 
therapy in young individuals (Bulik & Watson, 2012). In adults, different types of 
psychotherapy such as specialist supportive clinical management, cognitive 
behavioral therapy and interpersonal psychotherapy have demonstrated similar results 
(Bulik & Watson, 2012).  Pharmacotherapy with antidepressants may be a 
compliment but is not recommended as single treatment.  
About half of the patients fully recover, 30% partially improve and the remainder are 
chronically ill (Berkman et al., 2007). AN is a potentially life-threatening disorder 
with increased risk for premature death caused by starvation or suicide. A recent 
meta-analysis of 35 studies with a mean follow-up of 14 years found a standardized 
mortality ratio of 5.9 (95% CI: 4.2-8.3) (Arcelus et al., 2011). 
 
1.3 BULIMIA NERVOSA 
 
1.3.1 Clinical Characteristics 
BN is characterized by recurrent episodes of binge eating in combination with some 
form of inappropriate compensatory behavior. Binge eating is the consumption of an 
abnormally large amount of food coupled with a feeling of being out of control. 
Compensatory behaviors (aimed at preventing weight gain) include self-induced 
vomiting; the misuse of laxatives, diuretics, or other agents; fasting; and excessive 
exercise. 
The onset of BN usually occurs in adolescence or early adulthood and is most 
frequently seen in women who are of normal body weight (APA 2000). Although the 
gender ratio is approximately 9:1, women to men (Bulik et al., 1997; Hoek & van 
Hoeken, 2003), the diagnostic criteria themselves are gender-biased. In contrast to 
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women, men tend to present with a greater reliance of no purging forms of 
compensatory behavior such as excessive exercise. Considerations of differences in 
the clinical presentation of BN in men may lead to revised estimates (Fichter & 
Quadflieg, 1997; Levitan et al., 2001; Lewinsohn et al., 2002). Approximately 80% 
of patients with BN are diagnosed with another psychiatric disorder at some time in 
their life (Braun et al., 1994). Commonly comorbid psychiatric conditions include 
anxiety disorders, major depression, dysthymia, substance use, and personality 
disorders (Brewerton et al., 1995; Weltzin et al., 1995; Lilenfeld et al., 1997). 
Personality features of individuals with BN include some features shared with AN as 
high harm avoidance, perfectionism, and low self-esteem. Features more specific to 
BN include higher novelty seeking, higher impulsivity, lower self-directedness, and 
lower cooperativeness (Barraclough & Harris, 1998; Bulik, & Kendler, 1998; Fassino 
et al., 2004; Steiger et al., 2004). 
 
1.3.2 Diagnostic criteria 
A diagnosis of BN requires a minimum of three months of binge eating and 
compensatory behavior occurring twice a week or more (APA 2000), see below. 
Similar to AN, individuals have to report the undue influence of weight and shape on 
their self-esteem. In addition, BN is diagnosed secondary to AN, i.e., the illness is 
diagnosed as BN only if the criteria for AN are not met. Thus, to be diagnosed with 
BN, individuals should have a BMI greater than 17.5 or the equivalent in children and 
adolescents. The DSM-IV distinguishes two subtypes of BN based on the individual‟s 
compensatory behavior: purging (including vomiting and misuse of laxatives, 
diuretics, or enemas) and no purging (restricted eating and exercise). 
 
1.3.3 Epidemiology 
The estimated prevalence of BN is 1-3% among young females and 0.1-0.3% among 
men (Smink et al., 2012). For instance, Keski-Rahkonen and colleagues found a 
lifetime prevalence of 1.7% for BN in women from the 1975–1979 birth cohorts of 
Finnish twins (Keski-Rahkonen et al., 2009). There is support for a decrease in the 
incidence of BN since the early nineties of the last century (Currin et al 2005). The 
peak age of incidence of BN is 16-20 years of age. However, several studies suggest 
that age at onset of BN is decreasing (Keel et al., 2006; Smink et al., 2012). 
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Bulimia nervosa 
 
 Recurrent episodes of binge eating characterized by eating in a discrete period of 
time an  amount of food that is definitely larger than most people would eat and a sense 
of lack of  control over eating 
 Recurrent inappropriate compensatory behaviour in order to prevent weight gain, 
such as self-induced vomiting, misuse of laxatives, diuretics or other medications, 
fasting, or excessive exercise 
 The binge eating and inappropriate compensatory behaviours both occur, on 
average, at least twice a week for three months 
 Self-evaluation is unduly influenced by body shape and weight 
 The disturbance does not occur exclusively during episodes of AN 
 
Subtypes 
Purging type: The person regularly engages in self-induced vomiting or the misuse of 
laxatives, diuretics or enemas  
Non-purging type: The person uses other inappropriate compensatory behaviours, such 
as fasting or excessive exercise    (APA 2000) 
 
 
1.3.4 Etiology 
Historically, like AN, BN has been conceptualized as having sociocultural origins. 
Furthermore, substantial familial aggregation of BN has been reported (Kaye et al., 
1998). Twin studies reveal a moderate to substantial contribution of additive genetic 
factors (between 54% and 83%) and unique environmental factors to BN (Wade et 
al., 1999; Carter et al., 2003). Linkage analyses have identified areas on chromosome 
10p that may be associated with BN (Bailer et al., 2004). Numerous candidate genes 
have been studied for their role in the risk of the disorder (Van Furth, 2005). 
Ongoing biological studies suggest fundamental disorders in serotonergic function in 
individuals with BN (Bulik & Kendler, 1998; Wade et al., 1999). The ultimate 
understanding of the etiology of BN and of other disturbances that contribute to the 
development of inappropriate responses to satiety clues (Mitchell et al., 1991) will 
most likely include main effects of both biological and environmental factors as well 
as their interactions and correlations. 
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1.3.5   Medical complications 
Although BN is not typically associated with the serious physical complications 
normally associated with AN, patients commonly report physical symptoms such as 
fatigue, lethargy, bloating and gastrointestinal problems. Individuals with BN who 
engage in frequent vomiting may experience electrolyte abnormalities, metabolic 
alkalosis, erosion of dental enamel, swelling of the parotid glands, and scars and 
calluses on the backs of their hands.  Those who frequently misuse laxatives can have 
edema, fluid loss and subsequent dehydration, electrolyte abnormalities, metabolic 
acidosis, and potentially permanent loss of normal bowel function (Lasater & Mehler, 
2001).  
BN is also associated with endocrine disorders including amenorrhea/oligomenorrhea 
although most women with bulimia are of normal body weight. Some bulimic women 
may have low bone mass and particularly those with previous AN (Naessén et al., 
2006). 
 
1.3.6   Treatment and prognosis 
The primary goal of treatment for bulimia is to reduce or eliminate binge eating and 
purging behaviour. Nutritional rehabilitation, psychosocial intervention, cognitive 
behavioural psychotherapy (CBT) and family treatment are often employed. 
Establishment of a pattern of regular, non-binge meals, improvement of attitudes 
related to eating, encouragement of healthy but not excessive exercise, and resolution 
of co-occurring conditions such as mood or anxiety disorders are among the specific 
aims of these strategies (NICE 2004; APA 2006).  
In addition to psychotherapy, medical treatment can be necessary in many cases. The 
selective serotonin reuptake inhibitor (SSRI) fluoxetine, has been shown to reduce the 
frequency of binge eating and purging and is effective also in patients who are not 
depressed (Leombruni et al., 2006). 
Little is known about the long-term cause and outcome of BN. However, available 
data indicate remission rates up to 70% or more by 10-year follow-up of BN (Keel & 
Brown 2010). This ED is associated with lower mortality rates than AN. In a recent 
meta-analysis of 12 studies of patients with BN the overall standardized mortality 
ratio was 1.9 (95% CI: 1-4-2.6) (Arcelus et al., 2011). 
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1.4 EATING DISORDERS NOT OTHERWISE SPECIFIED  
 
1.4.1 Clinical Characteristics  
EDNOS is a diagnostic category that captures those individuals with ED who do not 
meet all criteria for AN or BN, see below. The patient‟s weight might be just above 
the diagnostic threshold for AN or she might still be menstruating. Binge eating and 
purging may occur less frequently than specified for a diagnosis of BN. Concern with 
weight and shape is generally present in these disorders, although in some the primary 
focus is on maintaining strict control over eating. Although the diagnostic criteria 
may not be met, many atypical ED are as severe and long lasting as AN and BN. 
Patients‟ treatment needs and prognosis may be virtually identical. 
A sub-type of EDNOS is the binge-eating disorder (BED). The defining 
characteristics of BED are consumptions of an objectively large amount of food in 
discrete time periods, a lack of control during eating episodes and a lack of 
compensatory behavior. BED affects approximately 30% of obese individuals seeking 
treatment. The binge eaters represent a distinct subgroup among the obese with higher 
prevalence of comorbid psychiatric disturbances, as well as higher rates of eating 
pathology, as compared to normal obese women (Latzer & Tzchisinki, 2003). 
 
1.4.2 Epidemiology 
EDNOS is the most common ED diagnosis made in most outpatient settings other 
than those that attract highly specialist referrals (Shafran & Fairburn, 2002). 
However, there are very few epidemiological studies on EDNOS, probably because 
of its heterogeneity. In a nation-wide community sample of young females, the point 
prevalence of EDNOS was 2.4 % (Machado et al., 2007). The lifetime prevalence of 
BED in European women has been estimated to 1.9% (Preti et al., 2009). 
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1.4.3 Diagnostic Criteria 
Diagnostic criteria for EDNOS according to DSM-IV (APA 2000) are shown below.  
 
Eating disorder not otherwise specified 
 
 All of the criteria for AN are met except that the individual has regular menses 
 All of the criteria for AN are met except that, despite significant weight loss, the 
individual‟s current weight is in the normal range 
 All of the criteria for BN are met except that the binge-eating and inappropriate 
compensatory mechanisms occur at a frequency of less than twice a week or for a 
duration of less than three months 
 The regular use of inappropriate compensatory behaviour by an individual of 
normal body weight after eating small amounts of food 
 Repeatedly chewing and spitting out, but not swallowing, large amounts of food 
 Binge-eating disorder (BED): recurrent episodes of binge-eating in the absence of 
the  regular use of inappropriate compensatory behaviours characteristic of BN 
                                                                                         (APA 2000) 
 
 
1.4.4  Etiology  
It has been a matter of debate whether EDNOS is a specific entity or not. Cross-
sectional studies generally demonstrate few clinical differences between individuals 
with full-syndrome AN or BN and their EDNOS (Thomas et al., 2009). The latter 
diagnosis is therefore commonly considered to be a residual category of AN or BN. 
However, there is support that patients with EDNOS have more comorbidity, such as 
depression and obsessive compulsive disorder, compared to BN (Schmidt et al., 2008). 
As with AN and BN, the cause of EDNOS is not determined but it is most likely a 
combination of environmental and biological factors that contribute to the development 
and expression of the disorder.  
 
1.4.5  Medical complications 
The medical problems associated with EDNOS are dependent on the type and severity 
of ED symptoms but similar to the full criteria syndromes of AN or BN. In adolescents 
with EDNOS it was demonstrated that partial AN was a more medically severe 
condition than partial BN, and that these categories differed more from each other than 
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from AN and BN, respectively (Peebles et al., 2010). Furthermore, many of those with 
BED will suffer similar physical complications of binge eating to those with BN, 
though purging carries greater physical risk than binge eating (Bulik & Reichborn-
Kjennerud 2003). Those who are obese are at risk of the psychological and physical 
disabilities associated with this condition, namely low self-esteem, diabetes, heart 
disease, hypertension and stroke. 
 
1.4.6  Treatment and prognosis 
Although there have been many studies of the course and outcome of AN and BN, 
few have considered EDNOS as a specific outcome. Treatment studies specifically 
for EDNOS are rare. However, in a recent small comparative study it was 
demonstrated that the treatment response to CBT, nutritional support and 
psychotropic drugs was 43% for patients with EDNOS and similar to BN and AN 
(Larrañaga et al., 2013). 
Remission rates at 20-year follow-up have been reported to be 75% for EDNOS 
compared to 72% for BN, with no significant difference between these rates (Keel & 
Brown 2010). Furthermore, remission rates do not appear to differ between different 
forms of EDNOS, i.e. partial AN, partial BN and BED (Keel & Brown 2010). A 
recent meta-analysis of six studies of patients with EDNOS reported an overall 
standardized mortality ratio of 1.9 (95% CI: 1.5-2.5) (Arcelus et al., 2011). 
 
1.5 DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS 
(DSM-V)  
 
Recently, the Fifth Edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-V) was released. Among the most substantial changes are recognition 
of BED, and revisions to the diagnostic criteria for AN and BN as summarized below: 
 
1.5.1 Binge Eating Disorder 
BED was approved for inclusion in DSM-V as its own category of ED. In DSM-IV, 
BED was not recognized as a disorder but rather described as a category of EDNOS. 
BED is defined as recurring episodes of eating significantly more food in a short period 
of time than most people would eat under similar circumstances, with episodes marked 
by feelings of lack of control. Someone with BED may eat too quickly, even when he 
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or she is not hungry. The person may have feelings of guilt, embarrassment, or disgust 
and may binge eat alone to hide the behavior. This disorder is associated with marked 
distress and occurs, on average, at least once a week over three months.  
 
1.5.2  Anorexia Nervosa 
AN, which primarily affects adolescent girls and young women, is characterized by 
distorted body image and excessive dieting that leads to severe weight loss with a 
pathological fear of becoming fat. The new criteria focus on behaviors, like restricting 
calorie intake, and no longer include the word “refusal” in terms of weight 
maintenance. The DSM-IV criterion amenorrhea will be deleted. This criterion cannot 
be applied to males, pre-menarchal females, females taking oral contraceptives and 
postmenopausal females. In some cases, individuals exhibit all other symptoms and 
signs of AN but still report some menstrual activity.  
 
1.5.3 Bulimia Nervosa  
BN is characterized by frequent episodes of binge eating followed by inappropriate 
behaviors such as self-induced vomiting to avoid weight gain. DSM-V criteria reduce 
the frequency of binge eating and compensatory behaviors that people with BN must 
exhibit from twice weekly to once a week. 
 
The above changes of the diagnostic criteria of ED do not influence the results and 
conclusions of the present thesis.  
 
1.6 EATING DISORDERS AND FERTILITY 
 
The reproductive capacity of women with ED is reduced depending on several factors. 
One of the diagnostic criteria for AN is amenorrhea. In AN, the usual mechanism of 
menstrual disturbance is hypothalamic amenorrhea due to starvation and low body 
weight (Chan & Mantzorors, 2005). Hypothalamic inhibition of the reproductive 
system will lead to a disruption of gonadotropin releasing hormone (GnRH) secretion 
from the hypothalamus. This will result in reduced pituitary secretion of luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH), leading to low production of 
estradiol from the ovaries, which will cause anovulation and amenorrhea. Because of 
anovulation, it is rare for AN women to become pregnant spontaneously although such 
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cases are reported. Furthermore, AN is associated with reduced libido and reduced 
sexual activity (Pinheiro et al., 2010).  
Women with BN also have menstrual disturbance in increased frequency even though 
they usually are of normal weight (Gendall et al., 2000; Naessén et al., 2006). Various 
mechanisms may explain oligomenorrhea and amenorrhea in bulimics. The temporary 
starvation periods associated with bulimia may be responsible for the hypothalamic 
inhibition of the reproductive axis, as well as low levels of thyroid hormones as in AN 
(Gendall et al 2000). Furthermore, several studies indicate a link between bulimic 
behavior and increased occurrence of polycystic ovary syndrome (PCOS) (Naessén et 
al., 2006). This suggestion is based on an increased frequency of polycystic ovaries, 
anovulation, elevated serum levels of testosterone and hirsutism in bulimic women 
(Naessén et al. 2006). 
Weight restoration seems to be the most important factor in recovering normal 
menstrual function among women with ED. However, impaired fertility may remain 
despite normal weight after recovery of an ED. Life-time history of both AN and BN 
has been associated with fertility problems, unplanned pregnancies and negative 
attitudes to pregnancy (Easter et al., 2011). In a recent register-based study, it was 
demonstrated that women treated for ED were more likely to be childless, and had 
lower pregnancy and childbirth rates than controls (Linna et al., 2013). 
 
1.7 PREGNANCY AND NEONATAL OUTCOME 
 
Even if fertility is reduced in women with ED, these disorders do not exclude 
spontaneous pregnancy. Women with ED may also become pregnant with assisted 
reproductive technologies. Furthermore, there is an increased risk of relapse of ED 
during pregnancy (Micali et al 2007). It has been reported that the prevalence of ED 
among pregnant women is more than 1 percent but it is probably higher than what is 
diagnosed because many patients hide their symptoms (Bulik et al., 2007). 
Data about the influence of ED on the course of pregnancy and delivery are scarce. 
Studies suggest that both AN and BN may have negative impact on pregnancy and 
perinatal outcomes.  Higher rates of maternal complications, such as miscarriages, 
hyperemesis, preterm delivery, intrauterine growth restriction and cesarean deliveries 
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have been reported (Bulik et al., 1999; Lacey & Smith, 1987; Brinch et al 1988; 
Mitchell et al., 1991; Franko et al., 2001).  
Little is also known about birth outcomes and the health of infants born to women with 
ED. The findings in the studies published before this thesis, suggest that both anorectic 
and bulimic behavior may affect fetal outcome negatively. However, most of these 
studies are retrospective reports or small prospective follow-up studies without control 
groups. 
Past or active ED have been associated with stillbirth, low birth weight, increased 
incidence of SGA and low Apgar scores in the offspring (Lacey & Smith, 1987; 
Stewart et al., 1987; Brinch et al 1988; Treasure & Russel, 1988; Conti et al., 1998; 
Franko et al., 2001). In a register-based study, the risk of SGA was reported to be 
nearly twice the size of the children of women with ED compared to children of healthy 
women (Petersen Sollid et al., 2004). Furthermore, individual studies have reported a 
high incidence of birth defects in infants of bulimics and increased perinatal mortality 
in children of women with previous AN (Lacey & Smith, 1987; Brinch et al 1988; 
Franko et al., 2001).  
It has been reported that ED symptoms may improve during pregnancy (Lacey & 
Smith, 1987; Blais et al., 2000; Crow et al., 2004). Binge-eating and self-induced 
vomiting decreased gradually during pregnancy in 20 women with BN (Lacey & 
Smith, 1987). However, after delivery the symptoms tended to return and in half of the 
women eating was more disturbed postpartum than before pregnancy (Lacey & Smith, 
1987;  Blais et al., 2000). Women with AN have also demonstrated improvements in 
ED symptoms during pregnancy, however, these symptoms returned to prepregnancy 
levels postpartum (Blais et al., 2000).  
 
1.8 EARLY ADJUSTMENT TO MOTHERHOOD 
 
1.8.1 Adjustment postpartum of healthy mothers 
After the birth of a child, the mother finds herself in an adjustment of life and attitude 
that not only brings physical changes but also much of her psychological life as well. 
Delivery does not immediately bring back the woman‟s previous body, perhaps 
intensifying psychological dynamics. Potential areas of concern for new mothers 
include infant feeding, maternal-child bonding, and postpartum adjustment. A 
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qualitative study of women who become mothers for the first time revealed the 
experience of unexpected hard work and exhaustion of caring for the baby, which can 
leave women confused and ambivalent about their early mothering experiences 
(Miller, 2011). In a Swedish prospective study it was demonstrated that maternal 
prenatal attachment during the third trimester of pregnancy is a good predictor of the 
postnatal mother-infant interaction (Hägglöf & Siddiqui, 2000). This knowledge can 
be used to identify women at risk for sub-optimal early mother-child interaction.  
 
1.8.2  Postpartum depression 
To have a baby, and particularly to become a mother for the first time, entails very 
great changes in maternal intrapsychic and interpersonal adjustment. It is well-known 
that childbearing and the postpartum period are associated with an increased risk of 
psychiatric disorders such as depression (Leight et al., 2010). Postpartum depression 
is a common and serious mental health problem. The prevalence is around 10% and 
the illness is associated with increased risk of suicide. Furthermore, postpartum 
depression is associated with disturbances in the mother-infant relationship. Risk 
factors for the disease are depression and or anxiety during pregnancy, premenstrual 
dysphoric disorder, stressful life events, poor social or partner support and low 
socioeconomic status (Leight et al., 2010). There is an on-going discussion and 
suggestion to introduce screening of postpartum depression in primary care.  
 
1.8.3  Early adjustment in mothers with eating disorders 
The postpartum period may be particularly stressful for women with ED. Over 40% of 
new mothers, regardless of having a diagnosis of an ED or not, report being 
dissatisfied with their weight during the postpartum period (Walker et al., 1988). Once 
the child is born, women often feel a need to lose the excess weight quickly and may 
use unhealthy measures to do so (Edelstein et al., 1992). Women with a history of ED 
who minimize their ED behaviours during pregnancy remain at high risk for relapse of 
ED behaviours during the postpartum period (Lacey & Smith, 1987; Blais et al., 2000). 
In fact, 80% of women with ED relapse in the postpartum period and attribute this to 
feeling fat and wanting to lose the weight gained during pregnancy (Lemberg et al., 
1989). 
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There are very few studies about ED mothers‟ early adaptation to motherhood apart 
from related to infant feeding. Brinch and co-workers (1988) reported in a 
retrospective study, that among 50 mothers with AN, 68% felt they had managed well 
in the maternal role, 25% that they had managed tolerably, and 7% that they had 
managed poorly. However, Woodside and Shekter-Wolfson (1990), found a high 
prevalence of parenting dysfunction and marital dysfunction in a small clinical sample 
of patients with AN and BN.  
 
1.8.4 Postpartum depression in women with eating disorders 
The psychosocial stressors of motherhood combined with body image concerns 
intensified by the bodily changes of the pregnancy, may predispose women with ED 
to the development of postpartum mood disorders. In a longitudinal study of 49 
women with AN and BN, Franko and co-workers (2001) found that 37% of the ED 
women experienced postpartum depression and mainly those with active ED 
symptoms during pregnancy. In agreement, a retrospective case-control study showed 
an increased risk for postpartum depression in women with active bulimia during 
pregnancy (Morgan et al., 2006). Furthermore, a population-based study concluded 
that women with lifetime BN and BED seem to be at particular risk of developing 
postpartum depression (Mazzeo et al., 2006). 
 
1.8.5  Feeding the infant 
Feeding is thought to be important in parent-infant bonding. Mothers with ED can 
exhibit problems in feeding their offspring starting during the postpartum period with 
breastfeeding (Lacey & Smith, 1987; Evans & Grange, 1995; Waugh & Bulik, 1999; 
Agras et al., 1999). Women with ED report a lack of desire to breastfeed and may 
experience difficulty in doing so (Stewart et al., 2001). One study found that 14 of 20 
mothers with BN reported having breastfeeding difficulties (Lacey & Smith, 1987). 
In addition, breastfeeding while restricting caloric intake may put the baby at risk for 
malnutrition. Women who worry that their child will become obese may be more 
likely to restrict that child‟s calories, which could lead to nutritional deprivation 
(Russel et al., 1998). Controlling parenting style in mothers with ED is associated 
with feeding problems in the offspring (Stein et al., 2001). Furthermore, children of 
mothers with ED may have an increased risk to develop disturbed eating behavior 
themselves (Stein et al., 2006). 
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1.9 GROWTH DEVELOPMENT IN THE OFFSPRING 
 
There is little information about the long-term consequences of maternal ED on 
growth development in the offspring. In an early report, seven infants born to mothers 
with AN were underweight at birth but caught up to normal weight at 30 weeks of age 
(Treasure & Russell 1988). In another study by Stein and co-workers (1996), 33 
infants of mothers with ED (BN and EDNOS) were found to have the same length, 
but to weigh less than control children at one year of age. However, follow-up at 10 
years of age showed no difference in BMI between the groups (Stein et al., 2006). 
Furthermore, Waugh and Bulik (1999) demonstrated in a small clinical material that 
children of women with ED (AN and BN) had significantly lower birth weights and 
lengths than controls, but these differences were no longer significant at three months 
of age. In a more recent large study by Micali and co-workers (2009), infants at nine 
months of age of mothers with self-reported BN (n = 194) were significantly more 
likely to be over-weight compared to the general population.  
To our knowledge, no previous study has investigated head circumference and 
neurocognitive development in children of mothers with ED.  
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2 OBJECTIVE 
 
2.1 OVERALL OBJECTIVE 
 
The overall objective of this thesis was to increase the knowledge about the influence 
of a history of ED on pregnancy complications and neonatal outcome, as well as the 
mother‟s adaptation to motherhood and the early growth and neurocognitive 
development of the child.  
 
 
2.2 SPECIFIC AIMS 
 
 To identify pregnancy complications in women with previous ED, and to 
describe neonatal outcomes (prematurity, SGA, and weight, height and head 
circumference at birth) as compared to healthy controls. 
 
 To compare early adaptation to motherhood in mothers with a history of ED and 
control mothers. 
 
 To describe growth pattern (weight, height from birth to five years of age and 
head circumference up to 18 months) and neurocognitive development up to five 
years of age in children of mothers with AN or BN before pregnancy compared 
to control children. 
 
 To describe levels of biomarkers of nutrition and stress in early pregnancy of 
women with a previous history of AN or BN and controls and to relate these 
results to head circumference at birth and neurocognitive development at five 
years of age of the offspring. 
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3 MATERIALS AND METHODS  
 
3.1 PROJECT DESIGN 
 
This is a longitudinal cohort study, in which women with a history of ED and healthy 
controls were followed from about pregnancy week 10 to three months after delivery. 
Pregnancy course and neonatal outcome were evaluated, as well as early maternal 
adjustment. Furthermore, growth development in children to the same mothers with 
previous ED and control children was followed from birth up to five years of age and 
cognitive development was evaluated at five years of age. The outline of the project is 
illustrated below: 
 
Pregnancy   Postpartum    Children’s growth                        Biobank sample 
analyses 
 3 months                            0- 5 years                                     
 
 
                                          
 
3.2 STUDY POPULATION OF WOMEN 
 
The initial study population consisted of forty-nine women with a history of ED (24 
AN, 20 BN, 5 EDNOS) and 67 controls. They were recruited in early pregnancy from 
13 prenatal clinics in the northwest area of Stockholm in early pregnancy. They were 
all nonsmoking, nulliparous and had conceived spontaneously. As part of the first 
prenatal visit, pregnant women with a history of ED received oral and written 
information about the study and were invited to participate. Women who were willing 
to participate were interviewed by a trained midwife about previous and present ED 
Paper I Paper II Paper III Paper IV 
    
Pregnancy and 
neonatal outcomes                                                       
Early adaptation to 
motherhood
Growth and 
cognitive 
development                              
Biomarkers of 
nutrition and stress 
    
49 women with ED, 
67 healthy controls                
44 women with ED, 
67 healthy controls                   
47 children to ED 
mothers, 65 control 
children                                 
37 women with ED, 
59 healthy controls        
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symptoms. These screening interviews were conducted between August 1997 and 
June 2001. The screening proceeded until 50 consecutive cases of pregnant women 
with a history of ED had been recruited. Another six screening-positive patients were 
not willing to participate further. 
The screening-positive participants were interviewed again to confirm previous and 
present diagnoses of AN, BN and EDNOS according to the diagnostic criteria of 
DSM-IV. The preliminary diagnoses were confirmed in each case. Information about 
the course and duration of the disease and about past or current therapy for ED was 
also obtained and confirmed from medical records when available. Table I 
demonstrates types of lifetime ED among the women. The mean duration of ED was 
nine years (range 3-15 years) and the duration of recovery before study recruitment 
was 2 (0.5-14) (median and total range) years. 
 
Table I. DSM-IV categories of life-time eating disorders before pregnancy 
Main Diagnosis                                                                                              N
Anorexia nervosa                                                              24
Bulimia nervosa                                                                                               20
Eating disorders not otherwise specified                                                         5
Total 49 
 
 
During the same time period, 68 controls were recruited from the same prenatal clinics 
by interview, using the same inclusion criteria as for the patients but without a history 
of ED. In each group of patients and controls there was one twin pregnancy diagnosed 
at the first ultrasound. These two pregnancies were excluded from the study. Thus, the 
final study population consisted of 49 women with a history of ED and 67 controls.  
 
3.3 ETHICAL APPROVAL (I, II) 
 
The research protocol was approved by the local Committee of Medical Ethics (97-
058) including supplement 2000-09-04, and informed consent was obtained from all 
women. 
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3.4 PROCEDURE STUDY I 
 
Pregnant women were assessed at weeks 10, 20, 25, 28, 31, 34, 36, and 40 of gestation 
according to routine prenatal care. Maternal measurements during pregnancy included 
weight, height, blood pressure, hemoglobin, and screening for gestational diabetes and 
preeclampsia. Apart from a screening ultrasound during weeks 16-18 of gestation, an 
extra ultrasound was performed during weeks 33-36 of gestation for measurement of 
fetal growth. Data on antenatal complications including hyperemesis, anemia 
(hemoglobin < 110 g/L), gestational hypertension, preeclampsia and gestational 
diabetes were collected from medical records. Gestational hypertension was defined as 
two or more antenatal systolic blood pressure readings of 140 mm Hg or more, or two 
or more antenatal diastolic readings of 90 mm Hg or more. Preeclampsia was 
diagnosed as blood pressure > 140/90 in combination with proteinuria ≥ 0.3 g/24 hours. 
Gestational diabetes was diagnosed as plasma glucose > 12.2 mmol/l after oral glucose 
tolerance test. Obstetric complications including intrauterine growth retardation and 
preterm delivery (before 37 completed weeks of gestation) were also evaluated. 
Intrauterine growth retardation was based on the second ultrasound examination and 
defined as fetal growth less than 22% of fetal growth distribution of a Swedish 
reference population (Marsal et al., 1996). Data of mode of delivery and obstetric 
complications such as induction of labor, vacuum extraction, and use of forceps, 
caesarian delivery and postpartum bleeding were evaluated from the medical records. 
Neonatal outcome parameters were also evaluated. The primary outcome variable was 
birth weight. Furthermore, data on length, head circumference, small for gestational age 
(SGA) and neonatal care were collected from medical records. SGA was defined as a 
birth weight less than two standard deviations of birth weight distribution of a Swedish 
reference population stratified by gender and gestational age at delivery (Persson & 
Weldner, 1986). Microcephaly was defined as less than two standard deviations of head 
circumference distribution of the same Swedish reference population.  
 
3.5 PROCEDURE STUDY II 
 
Three months after delivery, the same women as in study I were asked to participate in 
a questionnaire study about early maternal adjustment and mental health problems 
postpartum. The women with a history of EDNOS were not included in this study 
because of the small size of the subgroup.  Thus, the study population consisted of 44 
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women with a history of ED and 67 controls. The questionnaire was sent by mail to the 
women to be completed at home and was then sent back to the responsible midwife. 
 
3.5.1 Maternal adjustment and maternal attitude   
The maternal adjustment and maternal attitude questionnaire (MAMA) is a 60-item 
self-report survey developed by Kumar et al. (1984). The complete questionnaire 
consists of five subscales: body image, somatic symptoms, marital relationships, 
attitudes to sex, and attitudes to pregnancy and the baby. In this study, we used a 
postnatal version of the latter subscale regarding maternal adjustment and attitudes to 
the baby. It consists of 12 items and uses a four-point scale from 1 = never/not at all to 
4 = very often/very much during the last month (Table II). We have used the same 
Swedish version as used by Börjesson et al. (2005). The sum of scores was calculated 
for the whole subscale, range 12–48. Higher scores reflect lower levels of adjustment or 
more negative attitudes. There is no established cut-off point to distinguish between 
positive and negative maternal adjustment according to the MAMA questionnaire. We 
defined a less favorable adjustment to motherhood as a score of 3 or 4 in at least one of 
the 12 items. 
 
Table II. The 12 items of the MAMA questionnaire 
Item 
1. Have you been worrying that you might not be a good mother? 
2. Have you worried about hurting your baby? 
3. Have you had enough time for yourself since you had the baby?    
4. Have you regretted having the baby?     
5. Have you felt proud of being a mother?   
6. Have you been feeling happy that you have a baby?    
7. Has the thought of having more children appealed to you?      
8. Have you felt disappointed by motherhood?    
9. Have you enjoyed caring for your baby‟s needs?                        
10. Have you been wondering whether your baby will be healthy and normal? 
11. Has life been more difficult since the baby was born?            
12. Have you enjoyed feeding your baby?                       
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The test-retest reliability for the 12 items of the MAMA questionnaire was previously 
found to be satisfactory (0.84), as well as split-half reliability (0.73) (Kumar et al., 
1984). We calculated Cronbach‟s alpha for the MAMA and found internal consistency 
to be satisfactory high (alpha = 0.86). Furthermore, comparisons with other interview 
findings and questionnaire data have provided good evidence for criterion validity 
(Kumar et al., 1984).  
The patients were also asked if they had been in contact with the health services owing 
to depression or any other mental health problem during the first three months after 
delivery. 
 
3.6 STUDY POPULATION OF CHILDREN 
 
Growth and neurocognitive development of the children to the same mothers with 
previous ED and controls were followed up to five years of age. Two children born to 
mothers with a history of EDNOS were not included because one child died shortly 
after birth due to heart malformation and another child was lost to follow-up. One of 
the mothers in the control group was missed at follow-up and another mother in the 
same group declined to participate. Thus, the final study population comprised 47 
children born to mothers with previous ED (24 AN, 20 BN, 3 EDNOS) and 65 control 
children. 
 
3.7 ETHICAL APPROVAL (III) 
 
The research protocol was approved by the local Committee of Medical Ethics (04-
199/1), and informed consent was obtained from all mothers. 
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3.8 PROCEDURE STUDY III 
 
3.8.1 Weight, height, head circumference 
Data on weight and height at 3, 6, 12 and 18 months, and 3, 4 and 5 years of age were 
obtained from medical records at child health clinics, whereas data on head 
circumference was obtained from birth up to 18 months of age. The weight was 
recorded within 10 g, the height and head circumference (maximal fronto-occipital 
circumference) to the nearest mm. The weights, heights, BMIs and head 
circumferences were expressed as standard deviations below or above the mean of a 
large reference population of Swedish children used in the national pediatric health care 
for body growth monitoring (standard deviation score, SDS) (Albertsson Wikland et 
al., 2002). Measures of growth development were related to items in the subscale of the 
MAMA questionnaire.  
 
3.8.2 Neurocognitive function 
Neurocognitive function of the children was investigated at the age of five years by the 
use of a validated parent questionnaire, The Fife to Fifteen (FTF) (Kadesjö et al., 2004). 
This questionnaire was mailed and completed by the mothers. The complete 
questionnaire consists of 181 items on neurocognitive development divided into eight 
domains (motor skills, executive functions, perception, memory, language, learning, 
social skills, and emotional/behavioral problems) and their subdomains, but for children 
who are five years old the domain learning is not used. Table III shows the domains 
and subdomains used in the present study. The response alternatives to each statement 
were: 0 = “Does not apply”, 1 = “Applies sometimes/to some extent” or 2 = “Definitely 
applies”. Higher scores reflect difficulties in neurocognitive function, and scoring 
above the 90th percentile of a reference population was considered significant and 
clinically relevant.  
The FTF has relatively high internal consistency (Cronbach´s alpha 0.69-0.94) and an 
acceptable to excellent inter-rater and test-retest reliability (Kadesjö et al., 2004). The 
clinical validity and utility of the FTF have been demonstrated (Korkman et al., 2004, 
Trillingsgard et al., 2004). 
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Table III. Domains and subdomains of neurocognititive function of the Five to Fifteen 
questionnaire 
Domains Items   Subdomains   Items 
Motor skills 1-17                           Gross motor skills 1-7 
  Fine motor skills                   8-17 
Executive functions                18-42 Attention 18-26 
  Hyperactive/impulsive          27-35 
  Hypoactive 36-39 
  Planning/organizing             40-42 
Perception 43-60 Relation in space                  43-47 
Memory 61-71 Memory 61-71 
Language     72-92 Comprehension 72-76 
  Language skills                     77-89 
  Communication   90-92 
Social skills                             122-148 Social skills                           122-148 
Emotional/behavioral           149-181 Internalizing 149-154 
 
 
3.9 PROCEDURE STUDY IV 
 
A routine blood sample was collected during early pregnancy in connection with the 
first visit in about week ten of pregnancy at the prenatal clinic for screening of 
infections (hepatitis B, human immunodeficiency virus infection, syphilis, rubella) and 
blood typing. Remaining serum was stored at the biobank of Karolinska University 
Hospital. All women gave consent for the sample to be used for research purposes. 
Biobank samples from 37 women with a history of ED (20 AN, 17 BN) and 59 controls 
were available for analysis of biomarkers of nutrition (ferritin, thyroid-stimulating 
hormone (TSH), free thyroxine (T4), insulin, insulin-like growth factor I (IGF-I) and 
IGF binding protein 1 (IGFBP1) and stress (cortisol). Maternal serum levels of 
biomarkers were related to head circumference at birth and neurocognitive function at 
five years of age of the offspring. 
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3.10 ETHICAL APPROVAL (IV) 
 
The research protocol was approved by the local Committee of Medical Ethics 
(2011/815-32) and the Karolinska biobank (BbK-00682). 
 
3.11 ANALYTICAL METHODS OF SERUM BIOMARKERS 
 
Serum levels of ferritin were analyzed by a routine chemiluminiscent assay at the 
Department of Clinical Chemistry, Karolinska University Hospital. The detection limit 
was 0.2 µg/L and the total coefficient of variation (CV) was 8.6%. Cortisol was 
analyzed using the instrument Modular E170/Cobas E (Roche Diagnostics, Mannheim, 
Germany). CVs for total cortisol were 3.1% at 284 nmol/L and 3.8% at 750 nmol/L. 
The assay measures both the free fraction and protein-bound cortisol. Serum levels of 
thyroid-stimulating hormone (TSH) and free thyroxine (fT4) were measured with 
enzyme immunoassays involving direct chemiluminescence, as described previously 
(Naessén et al., 2006). Insulin was analyzed using a magnetic bead-based metabolic 
hormone panel from Millipore, Billerica, MA, USA (Cat# HMHMAG-34K-06). The 
plate reader was a Luminex MagPix (Millipore) and the plate washer was a Tecan 
Hydroflex (Tecan, Männedorf, Switzerland) fitted with a magnetic holder. The inter- 
and intra-assay CVs were 12.5% and 8.3%. Following separation from IGFBPs by 
extraction with acidic ethanol and cryoprecipitation, IGF-I was determined by 
radioimmunoassay (RIA) utilizing des [1-3] IGF-I as the radio ligand to minimize 
interference from any IGFBPs that might have still been present (Bang et al., 1991). 
The concentrations of IGFBP1 in serum samples were determined by RIA according to 
Póvoa and co-workers (1984).   
 
3.12 STATISTICS 
 
Power calculation for the initial study population was based on birth weight as the 
primary outcome variable. We included 50 patients and 68 controls to detect a 
difference between groups of approximately 10% with 80% power. Characteristics of 
the participants were presented as mean and standard deviation (SD) or median and 
inter-quartile range. In comparisons between women with different types of  ED and 
controls, one-way analysis of variance (ANOVA) followed by Fisher´s least significant 
difference test (LSD post-hoc test) (I, IV) was performed for continuous data and 
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Kruskal-Wallis test (II, III) followed by multiple comparisons between groups based on 
ranks for ordinal- or skewed distributed data. The p-values were then corrected 
according to the Bonferroni procedure. The Chi-square test and Fisher‟s exact test (I, II) 
were used for data measured on a nominal scale. In paper III, Mixed procedure with a 
random coefficient model was used to compare the subgroups of ED and controls 
regarding variables of growth development (measured as SD-scores) with adjustments 
for mother‟s BMI and the child‟s sex. Also in paper III, a general linear model was 
employed to compare the ED and controls regarding the growth at birth, 3, 6, 12, 18 
months and 3, 4, and 5 years of age with adjustment for mother‟s BMI, the child‟s sex 
and the true age. Correlations were evaluated with Spearman rank correlation or 
Pearson‟s product moment correlation coefficient (III, IV). Forward stepwise multiple 
linear regression analysis (III) was performed to evaluate the association between 
growth development and different background variables. To assess the significance of 
the difference between two correlation coefficient (III) Fisher‟s Z-transformation was 
carried out. P<0.05 was considered to be statistically significant. 
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4 RESULTS 
 
4.1 PREGNANCY CHARACTERISTICS OF PARTICIPANTS (I, II, III & IV) 
 
Physical and pregnancy characteristics of the initial study population of 49 nulliparous 
non-smoking women with a history of ED (AN (n = 24), BN (n = 20) and EDNOS (n = 
5)) and 67 healthy controls are shown in Table IV.  
Body weight and BMI in week 10 of gestation were significantly lower in the ED 
mothers than the controls but maternal weight gain did not differ between groups. 
However, weight gain in the subgroup of AN was significantly lower than the control 
group (p <0.05). Women with a history of ED were at increased risk of hyperemesis 
and anemia (hemoglobin < 110 g/L) evaluated at gestational week 25. Furthermore, 
gestational hypertension/preeclampsia, intrauterine growth restriction and cesarean 
section tended to be more common among the ED women. Weeks of gestation and 
events of preterm delivery were not significantly different between groups.  
 
Table IV. Physical and pregnancy characteristics in women with a history of ED and 
Controls  
 
 
  ED mothers 
  (n= 49) 
   Controls 
   (n= 67)                                                                
Significance 
    
Age (y) 29.3  ± 4.6 30.0 ± 3.7  
BMI (kg/m
2
) 20.5 ± 3.0 22.3 ± 2.8 < 0.001 
Maternal weight gain (kg) 11.3 ± 3.9 12.1 ±  2.6  
Hyperemesis (%) 33 9 < 0.01 
Anemia (%) 49 12 < 0.001 
Gestational 
hypertension/preeclampsia (%) 
12 3 0.07 
Intrauterine growth restriction (%) 8 0 0.07 
Weeks of gestation 38.9 ± 1.8 39.2 ± 1.8  
Preterm delivery (%) 18 12  
Cesarean section (%) 26 13 0.07 
 
Values are mean ± standard deviation or percentage 
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Eleven of the 49 patients (22%) had a verified relapse of ED during pregnancy. Of 
those, eight women were previously diagnosed with AN and three women had a history 
of BN and they relapsed to similar symptoms during pregnancy. 
 
4.2 NEONATAL OUTCOMES (I) 
 
Pregnant women with a history of ED delivered infants with significantly lower birth 
weight, whereas birth length was comparable to controls (Table V). The frequency of 
SGA was also significantly increased in infants of mothers with previous ED. When 
comparing subgroups of ED, birth weight was significantly lower only in the AN group 
but not in the BN group and there was no difference in length between groups (Figure 
1). Furthermore, there were no differences between those with and without verified 
relapse of ED during pregnancy. 
The main finding in this study was significantly smaller head circumference in children 
of mothers with a history of ED (Table V). Furthermore, the prevalence of 
microcephaly was 8% (2 AN, 1 BN, 1 EDNOS) in the same group of children but 0% 
in the control group. It is noteworthy that infants of both the anorectic and the bulimic 
subgroup had significantly smaller head circumference than controls although birth 
weight was lower only in the AN group (Figure 1). 
 
Table V. Neonatal characteristics in offspring of mothers with a history of ED and 
Controls  
 
 
Offspring of ED 
mothers  
  (n= 49) 
Offspring of 
control mothers 
   (n= 67)                                                                
Significance 
    
Weight (g) 3233 ± 606 3516 ± 515 < 0.01 
Length (cm) 49.6 ± 2.7 50.2 ± 2.4  
Head circumference (cm) 33.7 ± 1.4 35.2 ±  1.6 < 0.001 
Small for gestational age (%) 12 1 < 0.05 
Microcephaly (%) 8 0 < 0.05 
Malformations (%) 2 0  
 
Values are mean ± standard deviation or percentage 
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Figure 1. Birth weight, length and head circumference in offspring of mothers with a 
history of AN or BN and Controls. Values are medians and inter-quartile ranges (P25 – 
P75). *p < 0.05, **p < 0.01 and ***p < 0.001 in comparison to controls. 
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4.3 EARLY ADAPTATION TO MOTHERHOOD (II) 
 
The response rate to the MAMA questionnaire of early maternal adjustment was 100%. 
In this study, we found that 92% of the women with a history of AN or BN had a less 
favorable early maternal adjustment, as estimated with the MAMA questionnaire, in 
comparison to 13% in the control group (p < 0.001) (Figure 2). However, there were no 
differences between the subgroups of ED and no differences between patients having 
verified relapse during pregnancy compared to those not having this. Figure 2 shows 
the prevalence of women with a less favorable maternal adjustment for each item of the 
MAMA questionnaire. 
 
Figure 2.  The percentage of women in subgroups of ED and in the control group with 
less favorable maternal adjustment (MAMA score ≥ 3) for each item of the 
questionnaire. *p < 0.05, **p < 0.01 and ***p < 0.001 in comparison to controls. 
Bonferroni adjustments for multiple comparisons were performed. 
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In 11 of the 12 MAMA items, at least one subgroup of ED had signiﬁcantly higher 
mean score than the control group. The ED groups had the highest score for item 3 
(Have you had enough time for yourself since you had the baby?), item 7 (Has the 
thought of having more children appealed to you?) and item12 (Have you enjoyed 
feeding your baby?). For item 7, the BN group responded with significantly higher 
score than the AN group (p<0.05). 
Twenty-two mothers with ED (50%), of which ﬁve had a veriﬁed relapse of ED during 
pregnancy,  had been in contact with health services because of depression or other 
mental health problems within three months after delivery, as compared to 10% in the 
control group (p < 0.001). There were no significant differences between subgroups of 
AN and BN (Figure 3).  
 
  
Item 
1. Have you been worrying that you might not be a good mother? 
2. Have you worried about hurting your baby? 
3. Have you had enough time for yourself since you had the baby?    
4. Have you regretted having the baby?     
5. Have you felt proud of being a mother?   
6. Have you been feeling happy that you have a baby?    
7. Has the thought of having more children appealed to you?      
8. Have you felt disappointed by motherhood?    
9. Have you enjoyed caring for your baby‟s needs?                        
10. Have you been wondering whether your baby will be healthy and normal? 
11. Has life been more difficult since the baby was born?            
12. Have you enjoyed feeding your baby?                       
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Figure 3.  The frequency of mental health problems postpartum in women with a 
history of AN or BN and controls. ***p < 0.001 in comparison to controls.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ED women who had been in contact with health services postpartum due to mental 
problems had significantly higher MAMA score than patients not reporting such 
contact with the health services (p < 0.001). Figure 4 shows the percentage of women 
in subgroups of AN and BN and controls with a less favorable MAMA adjustment in 
three or more of the 12 items and who reported or did not report mental health 
problems postpartum. In the AN group, the percentage of women with a less favorable 
MAMA adjustment was significantly higher among those who reported mental 
problems postpartum (p<0.01). 
 
Figure 4.  The percentage of women in subgroups of ED and in the control group 
having a less favorable MAMA adjustment and who reported or did not report mental 
problems postpartum.  
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4.4 GROWTH DEVELOPMENT (III) 
 
Children of mothers with a history of ED demonstrated an early catch-up in weight and 
BMI but head circumference continued to be delayed until at least 18 months of age.  
The mean weight and BMI at birth of the children of mothers with previous ED were 
significantly lower than in the control children (p < 0.05, respectively) although 
gestational age was similar between groups. However, from the age of three months 
there were no longer any differences in weight and BMI between groups. Figure 5 
shows BMI in the infants of mothers with previous AN or BN and control children 
from birth to five years of age (p-values adjusted for the mother‟s BMI, the child‟s sex 
and the true age). BMI was lower at birth in both subgroups of infants born to mothers 
with AN or BN than controls but not at older ages. Similarly, the SDS of BMI in the 
AN group was significantly lower at birth (p < 0.05) but thereafter comparable to the 
controls, whereas the SDS of BMI in the BN group was comparable to controls at all 
time points. 
 
Figure 5. BMI at birth to five years of age in subgroups of children born to mothers 
with AN or BN and control children. The values are means and 95% CI and the figures 
are adjusted for the mother‟s BMI, the child‟s sex and the true age. 
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In contrast to BMI, head circumferences of the children born to mothers with ED were 
smaller throughout the observation period (p < 0.01- p < 0.001). Figure 6 shows head 
circumference in the infants of mothers with previous AN or BN and control children 
from birth to 18 months of age (p-values adjusted for the mother‟s BMI, the child‟s sex 
and the true age). Head circumference was significantly lower for both subgroups of 
ED compared to controls (p < 0.05-0.001, respectively). Furthermore, the SDS for head 
circumference was significantly lower over time in both the AN group and the BN 
group (p < 0.001, respectively). 
Dysfunctional answers to MAMA question 1 (Have you been worrying that you might 
not be a good mother?) correlated with an impaired increase in head circumference 
development (p < 0.01). This factor together with head circumference at birth and sex 
of the child explained 53% of the variance (R
2
) in head circumference development (p 
< 0.001). 
 
Figure 6. Head circumference at birth to 18 months of age in subgroups of children 
born to mothers with AN or BN and control children. The values are means and 95% 
CI and the figures are adjusted for the mother‟s BMI, the child‟s sex and the true age. 
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4.5 NEUROCOGNITIVE FUNCTION (III) 
 
The response rate to the FTF questionnaire of neurocognitive function was 96%. 
Children of mothers with ED had significantly higher mean raw scores of cognitive 
abilities (impaired function) for all domains (p < 0.05 – p < 0.001) except for 
perception (p = 0.10) and emotional problems (p = 0.07) than controls. There were no 
significant differences in mean domain raw scores for children of mothers with a 
history of AN and BN. Forty-one percent of children of  mothers with ED and 11% 
control children had a domain mean score above the 90
th
 percentile in one or more 
domains (p < 0.0001). Figure 7 shows the percentage of children of mothers with AN 
or BN and controls with impaired neurocognitive development at five years of age in 
different domains of the FTF questionnaire. The percentage of children of mothers with 
AN and BN with impaired function was significantly increased for motor skills and 
language skills, and the BN group also for memory function compared to controls 
(Figure 7). 
 
Figure 7. Percentage of children of mothers with AN, BN and controls with impaired 
neurocognitive development (score above the 90
th
 centile) in different domains of the 
FTF questionnaire. Bonferroni adjustments for multiple comparisons were performed. 
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In the children of mothers with ED, head circumference at birth correlated significantly 
with language skills (rs = 0.32, p < 0.05). In children to mothers with a history of BN, 
head circumference at birth also correlated with planning/organising (rs = 0.64, p < 
0.01) and social skills (rs = 0.51, p < 0.05). Similar correlations were not found in the 
AN group or the control group.  
 
4.6 BIOMARKERS OF NUTRITION AND STRESS (IV) 
 
Maternal serum biomarkers of nutrition (ferritin, TSH, T4, insulin, IGF-I and IGFBP1) 
and stress (cortisol) were determined in early pregnancy of the women with a previous 
history of AN or BN and controls. We found significantly lower serum levels of ferritin 
in women with previous AN (p < 0.05), but not in those with previous BN, compared to 
the controls (Figure 8). Only in the combined material of patients and controls, there 
was a positive correlation between serum ferritin and head circumference at birth of the 
offspring (rs = 0.21, p < 0.05). Furthermore, serum ferritin in the mothers with a history 
of AN was significantly associated with memory impairment of the offspring at five 
years of age (rs = -0.70, p < 0.001) (Figure 9). Similar association was not found in 
those with a history of BN (rs = 0.17, p = 0.52) and controls (rs = -0.23, p = 0.11).  
There were no significant differences between the groups in the other biomarkers 
investigated, including cortisol. However, maternal serum levels of free T4 were 
positively associated with head circumference of the children in the BN group (rp = 
0.48, p < 0.05) with the same tendency in the AN group (rp = 0.42, p = 0.07) but not in 
the controls (rp = 0.006).   
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Figure 8. Serum levels of ferritin in pregnant women with a history of AN or BN and 
controls. The dashed line indicates the normal lower range for pregnant women. Values 
are medians and inter-quartile ranges (P25 – P75). **p < 0.01 in comparison to 
controls. 
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Figure 9. Correlation between maternal serum levels of ferritin and raw scores of 
memory function (higher scores reflect impaired function) in the group of mothers with 
a history of AN.  
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5 DISCUSSION 
 
5.1 PREGNANCY AND NEONATAL OUTCOMES 
In this longitudinal cohort study (I) we demonstrated an increased rate of SGA and 
significantly lower birth weight in infants of nulliparous, nonsmoking women with a 
history of ED compared to healthy controls from the same living area, whereas birth 
length of the offspring was comparable between groups. When comparing the 
subgroups of EDs, we found that only the women with a history of AN had lower 
maternal weight gain and delivered infants with significantly lower birth weight than 
the controls.  
These results are in agreement with the majority of published studies at the time (Lacey 
& Smith, 1987; Stewart et al., 1987; Treasure & Russel, 1988; Conti et al., 1998; Bulik 
et al., 1999; Franko et al., 2001; Petersen Sollid et al., 2004), although a few reports 
suggested that pregnancy outcome was not affected by ED (Willis & Rand, 1988; 
Lemberg & Phillips, 1989). However, most of the studies were retrospective (Stewart et 
al., 1987; Conti et al., 1998 Bulik et al., 1999), or small follow-up studies without a 
control group (Lacey & Smith, 1987; Treasure & Russel, 1988; Franko et al., 2001). 
One exception was a large Danish register-based study, demonstrating a doubled risk of 
both SGA and low birth weight in children of mothers with a history of EDs compared 
to control women (Petersen Sollid et al., 2004). Later on, a Swedish register study also 
reported lower birth weight in newborns of women with a history of AN (Ekéus et al 
2006). However, in the Norwegian Mother and Child Cohort Study it was demonstrated 
that women with a previous diagnosis of BED delivered babies with higher birth 
weight, lower risk of SGA and higher risk of large for gestational age (Bulik et al 
2009). In our study, we had no woman with a history of BED. 
 
5.1.1 Head circumference 
A new finding in our study was smaller head circumference at birth and increased 
frequency of microcephaly in children of mothers with a history of ED. Similar data 
have never been reported before. The frequency of microcephaly of 8% in the ED 
group is considered high in comparison with 2.5% in the general population, using the 
same definition of microcephaly as in our study (Vargus et al 2001). Importantly, head 
circumference was significantly smaller in infants of both the AN and the BN 
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subgroups, although only the infants of the anorectic subgroup had lower birth weight 
than the offspring of controls. 
The mechanisms for lower birth weight and smaller head circumference in infants of 
mothers with a history of ED are not known. Gestational hypertension/preeclampsia 
and intrauterine growth restriction tended to be more common in the ED mothers than 
the controls. Whether these results also imply placental insufficiency in the ED group 
remain to be elucidated. Unfortunately, we have no information on placental tissues in 
our material. However, maternal smoking, as a well-known contributor to growth 
restriction, was excluded in this study. 
We hypothesized that nutritional deficiency and/or stress in the pregnant women with 
previous ED might be underlying causes for impaired neonatal outcomes. Low 
maternal BMI, reduced weight gain and high frequency of anemia among the pregnant 
women with previous AN clearly indicate nutritional deficiency in this subgroup. In 
contrast, the women in the BN group had BMI and pregnancy characteristics similar to 
the control group. This discrepancy between the subgroups might reflect different 
underlying mechanisms behind decreased head circumference in the infants. 
There is evidence that maternal stressors could influence fetal growth and brain 
development (Singh et al., 2012). Thus, fetal exposure to increased endogenous cortisol 
levels as a consequence of maternal stress has been associated with low birth weight 
and impaired mental and motor development in the infant (Buitelaar et al 2003, Singh 
et al., 2012). Animal studies have furthermore shown that prenatal exposure to 
synthetic glucocorticoids can have deleterious effects on brain development, including 
the hippocampus, as well as adverse behavioral and learning effects (Uno et al., 1994; 
Rodriguez et al., 2011). It has previously been demonstrated that ED is associated with 
elevated stress hormones including cortisol (Monteleone et al., 2001; Naessén et al 
2006). Moreover, poor maternal nutrition decreases placental activity of 11ß-
hydroxysteroid dehydrogenase type 2, thereby enhancing maternal cortisol production 
(Seckl et al., 2007). Hypothetically, maternal hypercortisolism in ED women could 
have an adverse on fetal brain development.   
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5.2 MATERNAL BIOMARKERS OF NUTRITION AND STRESS 
 
In order to explore possible mechanisms of impaired growth and head development in 
infants of mothers with a previous history of AN or BN, we investigated maternal 
serum biomarkers of nutrition and stress in these women and compared to controls 
(IV). In blood samples collected in early pregnancy and stored at the Karolinska 
biobank, we analyzed serum levels of ferritin, cortisol, TSH, free T4, insulin, IGF-I and 
IGFBP1and related to head circumference at birth and neurocognitive function at five 
years of age of the offspring.  
 
5.2.1 Ferritin 
In comparison to controls, we found significantly lower serum levels of maternal 
ferritin in women with a history of AN, but not in the BN group. This is in agreement 
with the highest frequency of anemia in the AN group (70%). In the combined group of 
patients and controls, there was a week positive association between maternal serum 
ferritin and head circumference at birth of the offspring. Furthermore, maternal serum 
ferritin correlated strongly with impaired memory of the offspring at five years of age 
in the AN group but not in the BN group or the controls.  
Iron is essential for normal fetal development including the brain and cognitive abilities 
of the infant, whereas iron deficiency during pregnancy is associated with increased 
risk of preterm birth and low birth weight (Milman, 2012). Other studies have also 
found associations between both low and high maternal levels of ferritin and preterm 
birth, preeclampsia and intrauterine growth restriction (Tamura et al., 1996; Hou et al., 
2000; Scholl, 2005; Soubasi et al., 2010). Serum ferritin is considered an indicator of 
iron stores and low levels diagnostic of iron deficiency. However, high levels of 
ferritin, particularly during the third trimester, may be secondary to acute-phase 
reaction in response to an acute or chronic infection (Tamura et al., 1996; Hou et al., 
2000). This could explain the diverse associations between maternal ferritin and 
pregnancy complications.   
Our results suggest that maternal iron deficiency in the mothers with a history of AN 
may negatively affect neurocognitive development of the infant. The same association 
was not found in the BN group and there seem to be different mechanisms for impaired 
head growth and neurocognitive development in children of mothers with a history of 
AN and BN.  
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5.2.2 Cortisol and thyroid hormones 
The other analyzed biomarkers, including cortisol, were comparable between the 
groups. Although both AN and BN are known to be associated with increased 
circulating levels of stress hormones like cortisol (Monteleone et al., 2001; Naessén et 
al 2006), there are no previous reports on serum cortisol in pregnant women with a 
history of ED. Thus, our data do not support the hypothesis of a link between maternal 
hypercortisolism in the ED women and reduced head circumference of the offspring.  
There is evidence that maternal thyroid hormone function is of great importance for 
neurocognitive development of the offspring (Haddow et al., 1999; Henrichs et al., 
2010; Li et al., 2010). There were no differences in serum levels of thyroid hormones 
between groups but we found clear positive correlations between maternal serum levels 
of free T4 and head circumference at birth in both subgroups of AN and BN but not in 
the controls. These results support a role of maternal thyroid hormones in 
neurocognitive development of the fetus. 
There are several limitations with the present study and the results should therefore be 
interpreted with caution. Serum biomarkers were determined only at one occasion in 
early pregnancy and there was no repeated blood sampling throughout pregnancy. Our 
results may therefore not be representative for the course of pregnancy. Furthermore, 
the blood sampling was not standardized according to time of the day and food intake. 
The sample size was also limited since not all blood samples of the cohort were 
available. 
 
5.3 EARLY ADAPTATION TO MOTHERHOOD 
 
Three months postpartum we investigated early adaptation to motherhood in our 
mothers with a history of ED and control mothers using the validated MAMA 
questionnaire (II). The main finding was that 92% of the women with a history of AN 
or BN had impaired adjustment to motherhood compared to 13% of the controls.  
Hardly anything is known from previous studies about the early relationship between 
mother and baby and bonding in women with a history of ED, a part from studies 
related to problems with infant feeding. Our results, based on self-reported data, 
indicate a high risk for a general impairment of early maternal adjustment in mothers 
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with previous ED. In average, they reported a score of less favourable adjustment in 
more than three of the 12 MAMA items. For instance, they perceive they have no 
longer enough time for themselves and the thought of having more children is not an 
appealing one. In 11 of the 12 items, at least one subgroup of ED had significantly 
higher mean score than the controls. There were no differences between subgroups of 
ED or between those having verified relapse of ED during pregnancy or not. 
Several studies have described feeding related problems in women with ED, starting 
with breast-feeding and continued during infancy (Lacey & Smith, 1987; Evans & 
Grange, 1995; Russel et al., 1998; Waugh & Bulik, 1999; Agras et al., 1999; Stein et 
al., 2001). However, these older studies have been limited by small sample sizes. 
Recently, a large longitudinal population-based study demonstrated that past and 
active ED during pregnancy increases the risk for infant feeding difficulties via 
maternal distress (Micali et al., 2011). Furthermore, the prospective Norwegian 
Mother and Child Cohort Study showed that mothers with BN and BED were more 
likely to report restrictive feeding styles and infant problems when their child was 36 
months old than mothers without ED (Reba-Harrelson et al., 2010). In agreement, we 
found that 70% in the BN group and 33% in the AN group compared to 1% in the 
control group reported dysfunctional answer to MAMA item 12: Have you enjoyed 
feeding your baby?  
 
5.3.1 Mental health problems  
We also demonstrated that 50% of the mothers with previous ED, as compared to 
10% in the control group, had been in contact with health services because of 
depression or other mental health problems postpartum.  These results are in line with 
several previous reports showing increased risk of postpartum depression in women 
with lifetime ED (Franko et al., 2001; Morgan et al., 2006; Mazzeo et al., 2006). In 
the study by Mazzeo and co-workers (2006), women with a history of BN and BED 
had the highest prevalence and three times the risk of postpartum depression than 
women without ED. In our study, there was no difference in frequency between the 
subgroups of AN and BN. 
It is obvious that women with a history of ED constitute a risk group for postpartum 
mental health problems including depression. It is therefore of great importance to 
identify these women as early as possible during pregnancy in order to give them 
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extra support and hopefully preventing the risk for mental illness and obstetric 
complications. 
 
5.4 GROWTH AND NEUROCOGNITIVE DEVELOPMENT IN THE 
OFFSPRING 
 
5.4.1 Growth development 
In a follow-up study of the children born to mothers with a history of ED (III), we 
characterized data on weight, height and BMI until five years of age and of head 
circumference up to 18 months of age and compared to control children. Furthermore, 
neurocognitive function was assessed at the age of five years and related to head 
growth. We were first to report retarded head growth throughout the observation period 
despite an early catch-up in BMI in children of mothers with previous ED. Moreover, 
reduced head circumference was related to delayed neurocognitive development in the 
same children. 
Significantly lower birth weight and BMI in the children of mothers with a previous 
history of ED were normalized already after three months. These results confirm 
previous reports (Treasure & Russell, 1988; Waugh & Bulik, 1999). In contrast, mean 
levels and SDS of head circumference (adjusted for the mother‟s BMI, the child‟s sex 
and the true age) were reduced up to at least 18 months of age in infants of both 
subgroups of mothers with AN or BN. Children who displayed the most pronounced 
delays in head growth were offspring of mothers who worried much about not being a 
good mother (MAMA item 1). 
Retarded head growth may be associated with impaired brain development. Our 
hypothesis is that nutritional deficiency and/or stress during pregnancy could be the 
underlying mechanisms. Poor fetal nutrition may impact on brain development and the 
risk of neuropsychiatric disease. The Chinese and Dutch famines have provided 
evidence in support of this theory (Altschuler, 2005; Kyle & Pitcherd, 2006; Penner & 
Brown, 2007). Furthermore, fetal growth may reflect maternal food intake, which is 
probably true for the AN subgroup. In this group, women were characterized by a low 
weight gain during pregnancy, high frequency of anemia and low levels of ferritin 
indicating nutritional deficiency. They delivered infants with both a low weight and a 
small head circumference. 
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In contrast, the infants born to mothers with BN had a normal birth weight, but a 
decreased head circumference. As pointed out earlier, this discrepancy between the 
subgroups might reflect different underlying causes behind delayed head growth. We 
suggested previously that fetal exposure to elevated levels of neuroactive steroids 
including cortisol, as a consequence of higher maternal stress, could affect brain 
development. However, our recent results of maternal serum biomarkers of nutrition 
and stress could not support this hypothesis since maternal levels of cortisol were 
comparable between the ED groups and the controls. 
An alternative factor of importance may be anxiety in the mothers since their answers 
to MAMA item 1 (Have you been worrying that you might not be a good mother?) 
correlated with delayed head growth in the offspring. It has furthermore been 
demonstrated that high levels of anxiety in pregnancy and postpartum are associated 
with active ED symptoms in pregnancy (Micali et al., 2009). However, the potential 
mechanism for how maternal anxiety might influence fetal growth remains to be 
elucidated.  
 
5.4.2 Neurocognitive function 
Neurocognitive development in the children was studied at the age of five years by the 
validated parent questionnaire FTF (III). The children of mothers with ED had higher 
mean raw scores (lower neurocognitive function) for motor skills, executive functions, 
memory, language skills and social skills than the control children. Forty-one percent of 
the children of mothers with ED and 11% of the control children had a score above the 
90
th
 percentile of a large national reference population in at least one domain, which is 
considered clinically significant. There were no significant differences in FTF scores 
between the ED subgroups, and both the AN and BN subgroups had scores reflecting 
difficulties in motor skills and language skills. 
Reduced head circumference at birth correlated significantly with impaired language 
skills in the children of mothers with ED. These results indicate that reduced head 
growth may be of importance for neurocognitive development in children born to 
mothers with ED. Furthermore, low maternal serum ferritin in mothers with a history of 
AN, but not in those with BN, correlated with impaired memory function in the 
offspring, suggesting that deficient iron stores in the AN mothers may negatively affect 
neurocognitive development of the infant. 
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5.5 CLINICAL CONSIDERATIONS 
 
Our results indicate that pregnant women with ED should be considered a risk group 
for serious health consequences, obstetric complications and impaired neonatal 
outcome. Health care needs to improve its methods to identify these women and 
optimize care in order to prevent adverse health effects for the mother and her baby. 
The father should also be involved in the support. In maternal care, there is a great need 
for increased knowledge about the role of ED for pregnancy, neonatal outcome and the 
child's development, and the way women at risk should be treated.  
A systematic use of screening for ED history early in pregnancy followed by an offer 
for a support program for identified pregnant women with ED history should probably 
reduce some of their stress and decrease the incidence rates of obstetric and neonatal 
complications. Motherhood could be a moment of opportunity since many women are 
motivated to make changes for the sake of their children.  
After parturition, attention should be paid to symptoms of depression in the mother and 
breastfeeding problems. Assessment of parenting skills early after delivery followed by 
appropriate interventions should improve coping strategies and the parent-child 
relationship, increase self-esteem and reduce feeling of inadequacy. On the long term, 
these interventions might reduce the risk for psychological disturbances in the children 
of mothers with a history of ED.  
 
5.6 A CRITICAL EVALUATION 
 
The present longitudinal cohort study has a number of significant strengths, such as an 
area-based sampling of the ED and control mothers to enhance generalizability; only 
nulliparous women and non-smokers were included; the diagnosis of ED was based on 
interviews; a longitudinal design; the period of the observation was prolonged and 
included repeated monitoring; there was no attrition up to 18 months of age of the 
children and little even up to 5 years of age. However, the sample size was limited; 
there was sparse information on breast-feeding and eventual feeding problems; and also 
a lack of information about a possible paternal influence. Furthermore, we have no data 
on head circumference of the parents. The MAMA questionnaire is based on self-
reported data and the FTF profiles were based on parent information of the mothers. 
Although the FTF test has demonstrated high inter-rater and test-retest reliability and 
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validity, we cannot exclude reporter bias due to the possibility of worries and feelings 
of guilt in the mothers with a history of ED. 
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6 GENERAL CONCLUSIONS 
 
 This longitudinal cohort study demonstrates that nulliparous nonsmoking pregnant 
women with past or active ED are at increased risk of hyperemesis and delivering 
infants with SGA and lower birth weight compared to healthy controls from the 
same living area. A new finding was also a significantly smaller head 
circumference and increased occurrence of microcephaly in children of mothers 
with a history of AN or BN. The proposed mechanisms behind these findings are 
deficient nutrient supply to the fetus and/or stress in the pregnant women. 
 
 Early adaptation to motherhood was clearly impaired and related to mental health 
problems postpartum in mothers with ED before pregnancy. Over 90% of 
nulliparous mothers with a history of AN or BN, compared to 13% of the controls, 
reported problems regarding their maternal adjustment and parenting during the 
first three months after delivery. Furthermore, 50% of the mothers with previous 
ED, as compared to 10% in the control group, had been in contact with health 
services because of depression or other mental problems. It should be notified that 
women with a history of ED are at increased risk for postpartum mental health 
problems indicating a strong need for support. 
 
 Children of mothers with a previous history of ED demonstrate an early catch-up 
in BMI from a decreased value at birth, but the head growth of children born to 
mothers with either AN or BN was retarded up to at least 18 months of age. 
Maternal stress and prenatal nutritional deficiency are possible causes of this 
delayed head growth. Our results also indicate that reduced head growth may be of 
importance for neurocognitive development in children born to mothers with ED 
who perceived difficulties in expressive language skills and social skills. Clinicians 
should be aware of the potential influence of maternal ED on head growth of the 
offspring to prevent later negative outcomes. 
 
 Low maternal serum ferritin in the AN group, but not in the BN group, seems to be 
of importance for the development of impaired memory capacity in the offspring at 
five years of age. Furthermore, the positive association between serum free T4 in 
pregnant mothers with previous ED and head circumference of the offspring 
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suggests that maternal thyroid hormone function also is important for fetal brain 
development. However, our study did not demonstrate maternal hypercortisolism 
in the mothers with previous ED. Therefore, these results give no support for our 
hypothesis of a link between high maternal serum cortisol, as a consequence of 
stress in the mothers with ED, and a reduced head circumference in the offspring. 
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